ArticleExpert review of anti-infective therapy2023

Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.

Andrew T Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.